Ítem
Acceso Abierto
The diagnostic performance of classical molecular tests used for detecting human papillomavirus
dc.creator | Munoz, Marina | spa |
dc.creator | Camargo, Milena | spa |
dc.creator | Leon, Sara C. Soto-De | spa |
dc.creator | Rojas-Villarraga, Adriana | spa |
dc.creator | Sanchez, Ricardo | spa |
dc.creator | Jaimes, Camilo | spa |
dc.creator | Perez-Prados, Antonio | spa |
dc.creator | Patarroyo, Manuel E. | spa |
dc.creator | Patarroyo, Manuel A. | spa |
dc.date.accessioned | 2020-05-25T23:56:43Z | |
dc.date.available | 2020-05-25T23:56:43Z | |
dc.date.created | 2012 | spa |
dc.description.abstract | Cervical samples were evaluated for human papillomavirus (HPV) presence using the hybrid capture-2 (HC2) assay and the polymerase chain reaction (PCR) with three different primer sets (GP5+/6+, MY09/11 and pU1M/2R). PCR results were compared to HC2 and results of all assays were compared to cytological and colposcopy findings. Post-test probability was assessed in individual assays and test combinations. HPV-DNA prevalence was 36.5% with HC2 and 55.2% with PCR. MY09/11 detected HPV-DNA in 38% of samples, GP5+/6+ in 19.1% and pU1M/2R in 16.4%. pU1M/2R and HC2 had the highest concordance (75.31%, k= 0.39 in the whole population; 74.1%, k= 0.5 in women with abnormal cytology). pU1M/2R had the best diagnostic performance, including optimal post-test probabilities and cervical abnormality detection (individually or in a panel of tests). Women positive for pU1M/2R may be at higher risk of disease progression; the assay performance when combined with a Pap smear in cervical cancer screening programs should be evaluated. © 2012 Elsevier B.V.. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1016/j.jviromet.2012.05.023 | |
dc.identifier.issn | 1660934 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/22494 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 38 | |
dc.relation.citationIssue | No. 1 | |
dc.relation.citationStartPage | 32 | |
dc.relation.citationTitle | Journal of Virological Methods | |
dc.relation.citationVolume | Vol. 185 | |
dc.relation.ispartof | Journal of Virological Methods, ISSN:1660934, Vol.185, No.1 (2012); pp. 32-38 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864324188&doi=10.1016%2fj.jviromet.2012.05.023&partnerID=40&md5=3165ee74600132b05b1a42afc665f3c4 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Virus DNA | spa |
dc.subject.keyword | Abnormal laboratory result | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Analytic method | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Cancer screening | spa |
dc.subject.keyword | Colposcopy | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Disease course | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | High risk population | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Human cell | spa |
dc.subject.keyword | Hybrid capture assay 2 | spa |
dc.subject.keyword | Intermethod comparison | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Papanicolaou test | spa |
dc.subject.keyword | Polymerase chain reaction | spa |
dc.subject.keyword | Post test probability | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Statistical parameters | spa |
dc.subject.keyword | Uterine cervix cancer | spa |
dc.subject.keyword | Uterine cervix cytology | spa |
dc.subject.keyword | Virus detection | spa |
dc.subject.keyword | Virus DNA cell DNA interaction | spa |
dc.subject.keyword | Wart virus | spa |
dc.subject.keyword | Adult | spa |
dc.subject.keyword | Cervix Uteri | spa |
dc.subject.keyword | Colposcopy | spa |
dc.subject.keyword | Cytological Techniques | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Molecular Diagnostic Techniques | spa |
dc.subject.keyword | Nucleic Acid Hybridization | spa |
dc.subject.keyword | Papillomaviridae | spa |
dc.subject.keyword | Papillomavirus Infections | spa |
dc.subject.keyword | Polymerase Chain Reaction | spa |
dc.subject.keyword | Prevalence | spa |
dc.subject.keyword | Sensitivity and Specificity | spa |
dc.subject.keyword | Virology | spa |
dc.subject.keyword | Young Adult | spa |
dc.subject.keyword | Human papillomavirus | spa |
dc.subject.keyword | Human papillomavirus | spa |
dc.subject.keyword | Hybrid capture assay 2 | spa |
dc.subject.keyword | Polymerase chain reaction | spa |
dc.subject.keyword | Screening | spa |
dc.subject.keyword | Test performance | spa |
dc.title | The diagnostic performance of classical molecular tests used for detecting human papillomavirus | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- 1-s2-0-S0166093412001863-main.pdf
- Tamaño:
- 345.97 KB
- Formato:
- Adobe Portable Document Format
- Descripción: